These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

616 related articles for article (PubMed ID: 33552062)

  • 1. Cytokine Storm in Coronavirus Disease 2019 and Adult-Onset Still's Disease: Similarities and Differences.
    Meng J; Ma Y; Jia J; Wang M; Teng J; Shi H; Liu H; Su Y; Ye J; Sun Y; Cheng X; Chi H; Liu T; Zhu D; Zhou Z; Wan L; Wang Z; Wang F; Qiao X; Chen X; Zhang H; Tang Z; Yang C; Hu Q
    Front Immunol; 2020; 11():603389. PubMed ID: 33552062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-18 Is a Potential Biomarker to Discriminate Active Adult-Onset Still's Disease From COVID-19.
    Chen PK; Lan JL; Huang PH; Hsu JL; Chang CK; Tien N; Lin HJ; Chen DY
    Front Immunol; 2021; 12():719544. PubMed ID: 34367188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease.
    Chen DY; Lan JL; Lin FJ; Hsieh TY
    J Rheumatol; 2004 Nov; 31(11):2189-98. PubMed ID: 15517632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current and emerging biological therapy in adult-onset Still's disease.
    Ma Y; Meng J; Jia J; Wang M; Teng J; Zhu D; Yang C; Hu Q
    Rheumatology (Oxford); 2021 Sep; 60(9):3986-4000. PubMed ID: 34117886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of Interleukin-18 as a Diagnostic Biomarker to Differentiate Adult-Onset Still's Disease With/Without Macrophage Activation Syndrome From Other Secondary Hemophagocytic Lymphohistiocytosis in Adults.
    Shiga T; Nozaki Y; Tomita D; Kishimoto K; Hirooka Y; Kinoshita K; Funauchi M; Matsumura I
    Front Immunol; 2021; 12():750114. PubMed ID: 34691064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adult-onset Still's disease.
    Gerfaud-Valentin M; Jamilloux Y; Iwaz J; Sève P
    Autoimmun Rev; 2014 Jul; 13(7):708-22. PubMed ID: 24657513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum sTREM-1 in adult-onset Still's disease: a novel biomarker of disease activity and a potential predictor of the chronic course.
    Wang Z; Chi H; Sun Y; Teng J; Feng T; Liu H; Cheng X; Ye J; Shi H; Hu Q; Jia J; Liu T; Wan L; Zhou Z; Qiao X; Yang C; Su Y
    Rheumatology (Oxford); 2020 Nov; 59(11):3293-3302. PubMed ID: 32276274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated serum gasdermin D N-terminal implicates monocyte and macrophage pyroptosis in adult-onset Still's disease.
    Nagai H; Kirino Y; Nakano H; Kunishita Y; Henmi R; Szymanski AM; Yoshimi R; Ombrello MJ; Nakajima H
    Rheumatology (Oxford); 2021 Aug; 60(8):3888-3895. PubMed ID: 33550379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adult onset Still's disease (AOSD) in the era of biologic therapies: dichotomous view for cytokine and clinical expressions.
    Maria AT; Le Quellec A; Jorgensen C; Touitou I; Rivière S; Guilpain P
    Autoimmun Rev; 2014 Nov; 13(11):1149-59. PubMed ID: 25183244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated serum levels of interleukin-10 in adult-onset Still's disease are associated with disease activity.
    Sun Y; Wang Z; Chi H; Hu Q; Ye J; Liu H; Cheng X; Shi H; Zhou Z; Teng J; Yang C; Su Y
    Clin Rheumatol; 2019 Nov; 38(11):3205-3210. PubMed ID: 31236746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive review on adult onset Still's disease.
    Giacomelli R; Ruscitti P; Shoenfeld Y
    J Autoimmun; 2018 Sep; 93():24-36. PubMed ID: 30077425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences and similarities in cytokine profiles of macrophage activation syndrome in systemic lupus erythematosus and adult-onset Still's disease.
    Hiyama T; Kurasawa K; Hasegawa A; Miyao T; Tanaka A; Arai S; Arima M; Maezawa R
    Clin Exp Med; 2023 Nov; 23(7):3407-3416. PubMed ID: 36611087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum cytokine profiles in patients with adult onset Still's disease.
    Choi JH; Suh CH; Lee YM; Suh YJ; Lee SK; Kim SS; Nahm DH; Park HS
    J Rheumatol; 2003 Nov; 30(11):2422-7. PubMed ID: 14677188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The specialized pro-resolving lipid mediator Protectin D1 affects macrophages differentiation and activity in Adult-onset Still's disease and COVID-19, two hyperinflammatory diseases sharing similar transcriptomic profiles.
    Navarini L; Vomero M; Currado D; Berardicurti O; Biaggi A; Marino A; Bearzi P; Corberi E; Rigon A; Arcarese L; Leuti A; Fava M; Fogolari M; Mattei A; Ruscitti P; Di Cola I; Sambuco F; Travaglino F; Angeletti S; Ursini F; Mariani E; Cipriani P; Agrò FE; Iagnocco A; Antonelli Incalzi R; Maccarrone M; Giacomelli R
    Front Immunol; 2023; 14():1148268. PubMed ID: 37153620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anakinra in patients with treatment-resistant adult-onset Still's disease: four case reports with serial cytokine measurements and a review of the literature.
    Kötter I; Wacker A; Koch S; Henes J; Richter C; Engel A; Günaydin I; Kanz L
    Semin Arthritis Rheum; 2007 Dec; 37(3):189-97. PubMed ID: 17583775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma microRNA Profiles as a Potential Biomarker in Differentiating Adult-Onset Still's Disease From Sepsis.
    Hu Q; Gong W; Gu J; Geng G; Li T; Tian R; Yang Z; Zhang H; Shao L; Liu T; Wan L; Jia J; Yang C; Shi Y; Shi H
    Front Immunol; 2018; 9():3099. PubMed ID: 30687316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Mac-2 binding protein glycosylation isomer and galectin-3 levels in adult-onset Still's disease and their association with cytokines.
    Yoshida S; Koga T; Fujita Y; Yatsuhashi H; Matsumoto H; Sumichika Y; Saito K; Sato S; Asano T; Kobayakawa M; Ohira H; Mizokami M; Sugiyama M; Migita K
    Front Immunol; 2024; 15():1385654. PubMed ID: 38711500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine profile, ferritin and multi-visceral involvement characterize macrophage activation syndrome during adult-onset Still's disease.
    Ruscitti P; Ursini F; Berardicurti O; Masedu F; Bozzalla Cassione E; Naldi S; Di Cola I; Di Muzio C; De Stefano L; Di Nino E; Navarini L; Vomero M; Bugatti S; Valenti M; Mariani E; Iagnocco A; Montecucco C; Giacomelli R; Cipriani P
    Rheumatology (Oxford); 2022 Dec; 62(1):321-329. PubMed ID: 35438139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating regulatory T cells in adult-onset Still's disease: Focusing on their plasticity and stability.
    Shimojima Y; Ichikawa T; Kishida D; Takamatsu R; Sekijima Y
    Clin Exp Immunol; 2021 Nov; 206(2):184-195. PubMed ID: 34319596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRP and sCD25 help distinguish between adult-onset Still's disease and HLH.
    Beckett M; Spaner C; Goubran M; Wade J; Avina-Zubieta JA; Setiadi A; Tucker L; Shojania K; Au S; Mattman A; Lee AYY; Fajgenbaum DC; Chen LYC
    Eur J Haematol; 2024 Nov; 113(5):576-583. PubMed ID: 38984483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.